Prolonged survival in patients with hand-foot skin reaction secondary to cooperative sorafenib treatment

Table 8 Prognostic factors of proportion of days covered by logistic regression analyses

	Adjusted analyses
	OR	95%CI	P value
Male	0.352	0.141–0.877	0.025
Child-Pugh stage B	3.830	1.180–12.400	0.025
Diarrhea	0.472	0.198–1.120	0.089
Group B vs Group A	0.113	0.036–0.356	< 0.001
Group B vs Group C	0.091	0.031–0.266	< 0.001